Related references
Note: Only part of the references are listed.Soluble-E-Cadherin Activates HER and IAP Family Members in HER2+and TNBC Human Breast Cancers
Sabine M. Brouxhon et al.
MOLECULAR CARCINOGENESIS (2014)
Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling
S. M. Brouxhon et al.
ONCOGENE (2014)
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
Antoinette Hollestelle et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Cadherin mechanotransduction in tissue remodeling
Floor Twiss et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy
G. Hofmann et al.
CLINICAL BIOCHEMISTRY (2013)
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC
Joana Figueiredo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
The Secretome Signature of Colon Cancer Cell Lines
Esther Imperlini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism
Khoi Chu et al.
ONCOTARGET (2013)
E-cadherin's dark side: Possible role in tumor progression
Fausto J. Rodriguez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Soluble E-cadherin: more than a symptom of disease
Magdalena M. Grabowska et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Serum protein levels following surgery in breast cancer patients: A protein microarray approach
Luis G. Perez-Rivas et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Clinical Significance of Serum Soluble E-cadherin in Colorectal Carcinoma
Yoshinaga Okugawa et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy
Fortunata Iacopino et al.
ONCOLOGY REPORTS (2012)
E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer
Joana Simoes-Correia et al.
PLOS ONE (2012)
Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP
Jakob V. Weiss et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Soluble Adhesion Molecules E-Cadherin, Intercellular Adhesion Molecule-1, and E-Selectin as Lung Cancer Biomarkers
Athena Gogali et al.
CHEST (2010)
Reverse phase protein microarrays advance to use in clinical trials
Claudius Mueller et al.
MOLECULAR ONCOLOGY (2010)
Molecular mechanisms controlling E-cadherin expression in breast cancer
Somesh Baranwal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The cell-cell adhesion molecule E-cadherin
F. van Roy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
E-Cadherin Tissue Expression and Urinary Soluble Forms of E-Cadherin in Patients with Bladder Transitional Cell Carcinoma
Benkang Shi et al.
UROLOGIA INTERNATIONALIS (2008)
Soluble cadherins as cancer biomarkers
Olivier De Wever et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery
Hanna C. Diehl et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Cadherins in development: cell adhesion, sorting, and tissue morphogenesis
Jennifer M. Halbleib et al.
GENES & DEVELOPMENT (2006)
Cadherin-catenin proteins in vertebrate development
Wen-Hui Lien et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin
AOO Chan et al.
CANCER (2005)
Regulation of cadherin-mediated adhesion in morphogenesis
BM Gumbiner
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Urinary levels of soluble E-cadherin in the detection of transitional cell carcinoma of the urinary bladder
SF Shariat et al.
EUROPEAN UROLOGY (2005)
E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast
TL Mastracci et al.
MODERN PATHOLOGY (2005)
Nerve Growth Factor mediates its pro-invasive effect in parallel with the release of a soluble E-cadherin fragment from breast cancer MCF-7/AZ cells
L Dolle et al.
JOURNAL OF DAIRY RESEARCH (2005)
Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients
C Wilmanns et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer
M Juhasz et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer
ACO Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy
K Matsumoto et al.
JOURNAL OF UROLOGY (2003)
Serum E-cadherin concentrations and their response during laparoscopic and open cholecystectomy
AJ Karayiannakis et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2002)
Expression of E-cadherin and catenins in early gastric cancer
YE Joo et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Soluble E-cadherin is a valid prognostic marker in gastric carcinoma
AOO Chan et al.
GUT (2001)
Share Paper
